EMERYVILLE, Calif. (AP) _ Zogenix Inc. (ZGNX) on Tuesday reported a loss of $37.8 million in its second quarter.
On a per-share basis, the Emeryville, California-based company said it had a loss of 89 cents.
The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 83 cents per share.
The drugmaker posted revenue of $1.1 million in the period.
Zogenix shares have risen 30% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $47.48, a drop of 16% in the last 12 months.